4th Quarter - Report

WEST FRONT STRATEGIES LLC for VIATRIS INC

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to FDA facility inspections, including HR 7006, Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Act; issues related to modernization of prescribing information for physicians and pharmacists; HR 6973, Enhanced Access to Affordable Medicines Act of 2022; HR 7032, Increasing Transparency in Generic Drug Applications Act of 2022.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7032 (117th), H.R. 7006 (117th), H.R. 6973 (117th)

Copyright/Patent/Trademark CPT

Issues related to Inter Partes Review and patent policy generally; Preserving Access to Affordable Generics and Biosimilars Act, S. 1428, H.R. 2891; Affordable Prescriptions for Patients Act, S.1435, H.R. 2873; Restoring the America Invents Act, S. 2891.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1428 (117th), H.R. 2891 (117th), S. 2891 (117th), H.R. 2873 (117th), S. 1435 (117th)

Budget/Appropriations BUD

Medicaid Rebate provision of the Bipartisan Budget Act of 2015 (CPI Penalty).

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Formulary placement of generics and biosimilar biological products in Part D, including the Ensuring Access to Lower Cost Medicines for Seniors Act, H.R. 2846; issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act of 2021, H.R. 2869 and S. 1427; issues related to rebate walls.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2846 (117th), S. 1427 (117th), H.R. 2869 (117th)

Labor Issues/Antitrust/Workplace LBR

Monitor issues related to antitrust and competition.

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues related to e-labeling; Generic Drug User Fee Amendments reauthorization; monitor issues related to Pharmacy Benefit Manager Transparency Act of 2022 (S.4293).

LobbyistCovered position, as disclosed
CHRISTOPHER BUKI —
ASHLEY DAVIS —
CRAIG KALKUT —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4293 (117th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.